Zero-Dollar Access

The case for making state-plasticity care free, available, and structurally guaranteed in America.

The vision presented in this excerpt exists beyond the boundaries of what current policy, regulation, reimbursement structures, and institutional incentives presently allow. That reality is acknowledged plainly. Existing systems were built for specific purposes, under specific assumptions, and meaningful change requires engagement with those systems as they are rather than as we might wish them to be. At the same time, no serious advancement has ever emerged from treating the present arrangement as the final word. Every meaningful improvement in public health, education, infrastructure, and human welfare began as a vision that exceeded the constraints of its day before finding its way into the world one practical step at a time. Every meaningful imagination turned reality tends to do the same. This work is therefore not offered as a declaration of what can be accomplished immediately. It is offered as a statement of direction. The central premise is simple: we consistently underestimate human potential because we habitually mistake current condition for permanent capacity. The person standing on the street is not necessarily the ceiling of what they can become. More often, they are the compressed version. Sometimes they are carrying the weight of poverty, trauma, chronic stress, illness, addiction, instability, or circumstances that have narrowed the range of what is presently accessible to them. There is a difference between a person and the conditions acting upon that person, and any society interested in human flourishing must learn to recognize it.

The challenge before us is not solely technical, legislative, or financial. It is philosophical. It requires a shift from asking what people currently produce to asking what becomes possible when people are given proper and welcoming access to the conditions that allow their capacities to emerge. Policy has long been organized around managing visible outcomes. The next chapter of progress may depend upon becoming equally serious about cultivating the conditions from which those outcomes arise. The practical details will vary. The direction should not.

Underlying this vision is a belief that remains both humble and profoundly consequential: human beings are frequently carrying far more within them than the world is presently able to see. When a person who has spent years believing there is no light at the end of the tunnel finally encounters a glimmer of light, something remarkable often follows. They do not just recover. They contribute. They build families, businesses, institutions, neighborhoods, ideas, and opportunities. They create stability where instability once existed. They expand possibility for others because possibility was once expanded for them. A society that learns how to restore human capacity at scale is not simply aiming at reducing suffering. It is increasing the number of people capable of carrying the future forward, with integrity. “The person on the street is not the ceiling of what they can become. They are the compressed version, sometimes not even of themselves, but of the circumstances. There is a difference, and it matters enormously. You revive a person’s spirit, who saw no light at the end of the tunnel, and they’ll build & install lights along tunnels for the rest of their life.”

What The Research Actually Means

In 2013, behavioral economists Sendhil Mullainathan and Eldar Shafir published findings that confirmed what many had long suspected but few had named with precision: scarcity taxes cognitive bandwidth. Not as a metaphor. As a measurable, replicable neurological reality. People navigating poverty perform worse on executive function measures not due to diminished capacity, but because their mental operating system is perpetually occupied by the arithmetic of survival. The finding circulated widely. It was cited, discussed, and acknowledged. And then, largely, it was filed away, processed intellectually without being fully integrated into how we build policy, design systems, or allocate resources. That gap between comprehension and integration is its own kind of problem. We understood the research. We did not yet feel the weight of what it was asking of us.

What it is asking is this: the cognitive suppression that chronic poverty produces is not incidental. It is structural. Sustained elevation of cortisol, the primary stress hormone, functionally suppresses the prefrontal cortex, the region responsible for long-range planning, impulse regulation, empathy, and the ability to hold a future in mind. Simultaneously, it amplifies amygdala activation, orienting the nervous system toward immediate threat at the expense of everything else.

This is not a temporary inconvenience. Extended exposure to this neurological configuration produces structural adaptation. The brain deepens the grooves it runs in. Defaults calcify. Range narrows. The longer a person lives inside that compressed state, the more their neural architecture organizes itself around it, making the very cognitive capacities that upward mobility requires harder and harder to access.

The brain state produced by chronic poverty is precisely the brain state that makes escaping poverty most difficult. That is not a coincidence. That is a mechanism. And mechanisms can be addressed.

Policy has spent generations treating this mechanism as a moral failing and designing interventions accordingly. Education programs, job training, financial literacy, all valuable, all insufficient on their own, because they are attempting to run advanced software on hardware that has been structurally compromised. The honest correction is to address the hardware.

The Biological Lever That Is Missing

Standard mental health care, including talk therapy, general psychiatric medication management, and community support services, addresses the margins of neurological change. These are not small things. They matter, and they should be preserved and expanded. But they do not possess the biological leverage required to break through what neuroscience refers to as the kinetic barrier: the brain's homeostatic resistance to changing its own architecture.

A nervous system that has been running in chronic stress configuration for years, or decades, has physically structured itself around that mode. The pathways are established. The defaults are strong. Addressing that through conversation alone is asking language to do the work of biology. At some threshold of severity and duration, it cannot.

High-efficacy state-plasticity interventions operate at a different level. They create the neurological conditions for structural change, not incrementally, but rapidly and measurably.

Ketamine & Rapid-Acting Interventions

Ketamine works through NMDA receptor antagonism, triggering a rapid glutamate surge that initiates synaptogenesis, the physical growth of new synaptic connections, within hours of administration. Clinical outcomes in treatment-resistant depression have been substantial and well-documented. What is less discussed is what this means for people whose depression is not merely clinical but environmentally continuous: the capacity to initiate structural brain change on a timeline that does not require months of incremental progress before a person can begin stabilizing their life.

Transcranial Magnetic Stimulation

TMS delivers targeted magnetic pulses to the dorsolateral prefrontal cortex, the region most directly suppressed by chronic stress activation. It physically upregulates activity in the area responsible for executive function, working memory, and future orientation. The intervention is non-invasive, requires no anesthesia, and has a well-established efficacy record in depression. Its application to populations carrying heavy allostatic load from sustained socioeconomic stress is underexplored and worth significant research investment.

Electroconvulsive Therapy

ECT carries a stigma inherited from its early history that bears no relationship to how it is practiced today. Modern ECT, delivered under general anesthesia with calibrated parameters, produces the most potent neurogenesis response available in clinical medicine. It triggers a substantial BDNF release, Brain-Derived Neurotrophic Factor, the primary driver of neural growth and repair, and has demonstrated outcomes in severe psychiatric presentations that no other intervention approaches. Its persistent underutilization is a policy failure, not a scientific one. What these interventions share is a capacity to materially expand accessible state range. Not simply symptom relief, though that is real and significant, but the reconstruction of the neurological reservoir from which different modes of thinking, planning, relating, and building become genuinely available. They do not alter who a person is. They restore the biological conditions under which a person can more fully become who they are.

You cannot bootstrap your way out of a compressed nervous system that has already passed a certain threshold of severity. Biology always requires a biological response.

The Economics Require Honest Accounting

The United States currently spends an estimated $20,000 per unhoused person per year in emergency services, law enforcement interactions, hospital utilization, and shelter operations. That figure is not an investment. It is the cost of a system that addresses the acute expressions of an untreated chronic condition without ever addressing the condition. A full TMS treatment course runs between $6,000 and $12,000. A ketamine infusion series between $3,000 and $6,000. A course of ECT between $2,500 and $10,000, depending on the number of sessions and the clinical setting. These are short-course, time-limited interventions, not ongoing maintenance expenses. When weighed against the annual recurring cost of unhoused status, the arithmetic is unambiguous.

The National Alliance on Mental Illness estimates the economic burden of untreated mental illness in the United States at over $193 billion annually in lost earnings. That figure does not capture emergency service utilization, incarceration costs, child welfare system involvement, or the downstream educational and economic effects on children of adults in chronic psychiatric crisis. When the full cost accounting is done, the investment in high-efficacy neurological intervention is not a budget question. It is a question of whether we are willing to look clearly at what our current non-investment is costing.

Zero-dollar access to state-plasticity care is infrastructure spending. It belongs in the same category as roads, water systems, and public education, foundational investments in the conditions that make everything else possible. The return is not only abstract. It is directly measurable in reduced emergency utilization, workforce reentry, housing stability, recidivism reduction, and the interruption of intergenerational transmission of biological disadvantage.

The Generational Ceiling

Epigenetic research has produced findings that carry implications most policy conversations have not yet absorbed. Chronic stress and sustained biological adversity do not affect only the individual who experiences them. They modify gene expression in ways that are, in part, heritable. Children of chronically stressed parents can enter the world with nervous systems already oriented toward threat, with diminished baseline capacity for the calm-state architecture that supports learning, attachment, and development.

This is not a permanent sentence. Neuroplasticity is real across the lifespan, and the capacity for structural change does not disappear. But it is not free, and it is not evenly distributed. It requires conditions, stability, adequate rest and nutrition, safety, and in cases where the depth of the groove has exceeded what environmental change alone can address, access to interventions with sufficient biological leverage to initiate genuine structural repair.

Every generation of unaddressed neurobiological burden is a structural contribution to the next generation's ceiling. The intervention that reaches one person reaches, in meaningful biological and behavioral ways, their children as well. This is the poetry that should make our hearts sing.

Universal zero-cost access to state-plasticity care is, among other investments, a generational one. If we’re being honest, it’s a first of our species investment. A person who receives genuine substrate repair and the support structure to consolidate it is less likely to transmit the biological signature of unresolved chronic stress to their children and to their society. Notice I say their — when you resolve chronic stress, you can feel all of the years of socialization that are within you, and your duty toward others is restored. The investment compounds forward just as the damage has compounded backward. The honest framing is not that we are spending money on individuals. We are interrupting a cycle that has been running largely unchallenged for generations.

What Repair Actually Produces

The most consistent pattern in the literature on post-traumatic growth, and in the broader history of human contribution, is that people who have been through genuine compression and received proper repair do not typically return to a prior baseline. They expand past it. The experience of having been narrowed down, to almost nothing, and then being given the conditions to rebuild, tends to produce an orientation outward. Toward others. Toward community. Toward problems larger than themselves. The neuroscience offers a plausible account of why. A nervous system that has been under severe chronic constraint, when that constraint is genuinely released and the plasticity window is properly supported, frequently undergoes more than recovery. It reorganizes. New range does not simply restore old defaults, it creates the neurological substrate for states that were not previously accessible. Greater capacity for perspective-taking, longer time horizon, increased tolerance for complexity, stronger social cognition.

This is not a peripheral benefit of the policy. It is the central one. What we are talking about is not merely reducing suffering, though that would be sufficient justification on its own. We are talking about recovering and activating human capacity that is currently dormant under conditions of neurological compression, capacity that, once released, has a documented tendency to extend itself outward into families, communities, and broader social fabric.

Give a person genuine biological repair and the support to consolidate it, and you are not simply helping that person. You are introducing into the surrounding community someone whose range has expanded, and expanded range, in a human being, tends toward contribution.

The human potential that chronic unaddressed neurobiological compression is suppressing in this country is not a small number. It is not a marginal adjustment. It is an enormous, largely invisible, and almost entirely recoverable loss. The policy response appropriate to that reality is not incremental. It is structural.

The Policy Architecture

The following represents a coherent, executable policy framework. None of these mechanisms require new bureaucratic infrastructure from scratch. They require political will, appropriate funding, and the willingness to treat neurological care as the public health infrastructure it is.

1. Federal Reimbursement Reform

Medicare and Medicaid coverage criteria for ECT, TMS, and esketamine are currently restrictive enough to exclude the majority of people who would benefit from them. Prior authorization requirements add delay and attrition to care pathways for populations that cannot sustain either. The immediate legislative correction is expansion of reimbursement criteria across these interventions, elimination of prior authorization for evidence-based high-efficacy treatments, and enforcement of full parity under the Mental Health Parity and Addiction Equity Act. These interventions are evidence-based medical treatments that belong in the standard coverage framework without exception.

2. A Federal Zero-Dollar Access Program

A dedicated federal funding mechanism, modeled on the Ryan White HIV/AIDS Program, which successfully eliminated cost as a barrier to life-altering treatment for a defined high-need population, should be established specifically for high-efficacy neurological and psychiatric interventions for unhoused and zero-income individuals. Administration through existing Federally Qualified Health Center infrastructure avoids the cost and delay of building new delivery systems. The FQHC network already operates on sliding-scale and no-cost models in underserved communities. Capitalizing it for neuromodulatory care delivery is an extension of existing infrastructure.

3. Mobile Clinic Infrastructure

Geographic concentration of high-efficacy intervention capacity in academic medical centers and urban private clinics is a distribution failure. Mobile clinic models have demonstrated effectiveness in addiction medicine and primary care delivery to unhoused populations. A federally funded mobile neuromodulatory clinic initiative, piloted initially in five to eight cities with the highest rates of unsheltered homelessness, would establish proof of concept, generate outcome data, and create a replicable deployment model. Outcome metrics should include housing stability at six and twelve months, workforce reentry, emergency service utilization reduction, and validated measures of executive function and cognitive range.

4. Workforce Expansion Through Task-Shifting

Psychiatrist shortage is a structural constraint that cannot be resolved quickly through training pipeline adjustments alone. TMS administration does not require a psychiatrist. It requires trained, supervised technicians. Ketamine infusion protocols can be safely administered under nurse practitioner or anesthesiology supervision in community settings. A credentialing and training program for community health workers in supervised neuromodulatory care administration, developed in coordination with existing psychiatric oversight structures, expands delivery capacity without waiting for residency pipeline solutions that are years away.

5. Integrated Support During The Plasticity Window

The research on outcomes following high-efficacy neurological intervention is consistent on one point: durability depends on what happens in the weeks following treatment. A brain that has undergone structural change through ketamine, TMS, or ECT is in an elevated state of plasticity, more responsive to new inputs, and more susceptible to destabilizing ones. Intervention delivered without concurrent stabilization support, housing assistance, case management, peer support, and basic material security, produces outcomes that are real but attenuated. The policy framework must integrate these support structures as critical clinical components.

The Specific Asks

This is a call to action directed at federal legislators, state health administrators, philanthropic funders, and research institutions. The following are specific, executable, and overdue. Expand Medicare and Medicaid reimbursement criteria for ketamine, esketamine, TMS, and ECT. Eliminate prior authorization requirements for these interventions. Enforce Mental Health Parity Act compliance without exception. Establish and capitalize a federal Zero Dollar Access program modeled on the Ryan White HIV/AIDS Program, administered through the existing FQHC network, targeting unhoused and zero-income populations as the primary beneficiary cohort. Fund a mobile neuromodulatory clinic pilot in five to eight high-need cities with rigorous outcome measurement across housing stability, cognitive function, workforce reentry, and emergency service utilization. Mandate public reporting of results within 24 months.

Direct the National Institute of Mental Health to establish a funded research initiative specifically examining cognitive, social, and economic outcomes of high-efficacy state-plasticity intervention in chronically disadvantaged populations. The current research gap in this area is not scientifically justified. Develop and implement a federal credentialing framework for community health workers in supervised neuromodulatory care administration. Begin with TMS and ketamine protocols. Build toward a workforce that can deliver these interventions at the community level within five years.

Require that any federal funding for high-efficacy neurological intervention include integrated support services, housing assistance, case management, and peer support, as clinical components of the care model, not optional supplementary services.

The infrastructure for a different outcome already exists in large part. What is required now is the commitment to use it for everyone.

The current arrangement, in which the interventions most capable of materially restoring neurological function are available primarily to people who can afford private care, is not a natural condition. It is a policy choice. And it is one that carries an enormous, largely unacknowledged cost: in human suffering, in suppressed potential, in the downstream economic and social consequences of preventable neurobiological compression that we continue to absorb instead of address.

The science is established. The mechanisms are understood. The delivery infrastructure is largely in place. The economic case is clear. What is being asked here is not innovation. It is execution, the willingness to take what we already know and build policy around it with the seriousness it deserves.

The Warm Direction · Hickson Endeavours · All Rights Reserved

Medical Disclaimer: This information is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.

Jay Lee is the founder of Hickson Endeavours, a behavioral intelligence holding company operating across elite sport, behavioral health, organizational consulting, public sector systems, and residential and community development. He writes at The Warm Direction.